Ads
related to: immunology
Search results
Biogen enters deal to acquire HI-Bio for $1.8bn
Pharmaceutical Technology via Yahoo Finance· 6 days agoBiogen has signed a definitive agreement to acquire clinical-stage biotechnology company Human Immunology Biosciences (HI-Bio) in a $1.8bn deal. The...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 5 days agoHuman Immunology Biosciencesn is focused on targeted therapies for patients with severe...
Feeding peanuts to young children can reduce allergy risk: Study
The Hill via Yahoo News· 9 hours agoChildren who consume peanut products in the first five years of their lives are less likely to...
Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology
FierceBiotech· 7 days agoBiogen is placing a $1.15 billion bet on Chris Viehbacher’s diversification vision. The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio ...
Biogen is buying up an immune drug developer for $1.8 billion
Quartz· 7 days agoBiotechnology giant Biogen said on Wednesday that it is acquiring immune drug developer Human ...
Biogen in up to $1.8 billion deal as rare diseases take center stage
Reuters via AOL· 7 days agoHuman Immunology's (HI-Bio) felzartamab has completed mid-stage studies for a type of kidney disease...
Biogen to buy Peninsula startup developing a drug for kidney disease for $1.2 billion - San...
The Business Journals· 6 days agoBiogen Inc. is shelling out $1.15 billion upfront to buy HI-Bio, a South San Francisco immunology...
Biogen to Buy Human Immunology Biosciences for Up to $1.8 Bln
Market Watch· 7 days agoBiogen is buying the privately-held biotechnology company Human Immunology Biosciences for as much as $1.8 billion in a move to expand its immunology portfolio ...
Study reveals circadian clock can be leveraged to enhance cancer immunotherapy
Medical Xpress· 9 hours agoA multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock—the biological pacemaker that governs daily rhythms in physiological processes ...
Biogen in up to $1.8 Billion Deal as Rare Diseases Take Center Stage
US News & World Report· 7 days agoHuman Immunology's (HI-Bio) felzartamab has completed mid-stage studies for a type of kidney disease called primary membranous nephropathy, and in patients with a disease ...